Wellfully, page-12

Appreciate the civil dialogue, ta.
The last para is hard to argue against, the current BOD versus the former is miles apart in credentials. What will truly differentiate the two (in the future) is the ‘effectiveness’ of the current BOD to realize the potentials of its IP.
At this time, arguably, they are much and much the same; P&G deal with old BOD and the current deal with the new BOD. In the interim has been a share consolidation and a depreciating sp. At this time you would have to give the ‘nod’ to the former.

Dead end road?..... this deal is in its infancy and whether it is a dead end or opens to other roads is yet to be determined.

That previous BOD were ‘incompetent’ a big call, they did engineer a deal that ‘saved’ this company, as have this BOD with its current deal, P&G a far bigger name then the Russian entity.

Not sure how much ‘control’ Wellfully really has .... as hoofa has pointed out; if Boak was the only ‘bidder’ the deal will be definitely skewed to their benefit.

Wellfully will have to have follow up deals elsewhere; think the Bodyguard is up against it; existing products out there already?, really need a main stream product that is not at the mercy and whim of consumers in a fast moving product environment. Surface hygiene, (my old favorite) would have been great, but .... ?

What can Wellfully pursue that become a mainstream product that will last the test of time?

Imo, not advice.